Skip to main content
Log in

Pharmacologic undertreatment of osteoporosis in Austrian nursing homes and senior's residences

Pharmakologische Unterversorgung der Osteoporose bei österreichischen Pflege- und Pensionistenheimbewohnern

  • original article
  • Published:
Wiener klinische Wochenschrift Aims and scope Submit manuscript

Zusammenfassung

Die Osteoporose ist eine klassische, altersabhängige Erkrankung. Obwohl in den vergangenen Jahren wesentliche Erfolge bei der Behandlung der Osteoporose erzielt und die Antifraktur-Wirkung einiger Medikamente bestätigt werden konnte, ist die Unterversorgung der Osteoporose nach wie vor ein wesentliches Problem. Bis dato existieren nur wenige Studien, die sich spezifi sch mit der Osteoporose und ihrer Behandlung in österreichischen Pflege- und Pensionistenheimen auseinandersetzen. Um die Häufigkeit der diagnostizierten Osteoporosefälle sowie die Verschreibung von Medikamenten gegen die Osteoporose zu untersuchen, haben wir eine Erhebung bei 89 teilnehmenden Institutionen durchgeführt. Die Daten wurden durch einen Fragebogen erhoben und mittels deskriptiven statistischen Verfahren ausgewertet. Das Durchschnittsalter der Heimbewohner betrug 82 Jahre, wobei der Großteil weiblich war (76 %). Die Hälfte der Bewohner nahm 5–8 verschiedene Medikamente pro Tag ein; 23 % erhielten sogar mehr als 8 Medikamente. Bei fast einem Viertel (21,2 %) der Heimbewohner lag die Diagnose einer Osteoporose vor. Die Anamnese einer Hüftfraktur lag bei 10,4 %, die einer anderen Fraktur bei 13,2 % vor. Lediglich 8,2 % der Bewohner wurden mit Kalzium, 6,2 % mit Vitamin D und 9,3 % mit einer Kombination aus Vitamin D und Kalzium behandelt. Nur bei 7,2 % war eine spezifi sche Osteoporosebehandlung verordnet worden. Zusammenfassend zeigt unsere Studie bestehende Mängel bei der Diagnose der Osteoporose in den österreichischen Pflege- und Pensionistenheimen auf. Die Daten unserer Erhebung weisen sehr deutlich darauf hin, dass die Osteoporose nach wie vor gerade in dem Bevölkerungsanteil, bei dem das größte Frakturrisiko besteht, nicht ausreichend versorgt wird.

Summary

Osteoporosis is a classical age-related disease. Although significant progress in treatment has been achieved and antifracture efficacy proven over the past years undertreatment is still a general problem. There are only few published data available regarding osteoporosis and its treatment encountered in Austrian nursing homes and seniors' residences where fractures are especially frequent. We therefore conducted a survey in 89 participating institutions in order to assess frequency of documented osteoporosis as well as prevalence status of anti-osteoporotic drug usage in this special population. Data were acquired using a questionnaire and analyzed in a descriptive manner. Mean age of the residents was 82 years and the majority was female (76%). Half of the subjects took 5–8 different drugs per day and 23% received more than 8. Almost onefourth (21.2%) of the residents had a diagnosis of osteoporosis. A history of hip fracture or other fractures was documented in 10.4% and 13.2%, respectively. Only 8.2% of the residents were treated with calcium, 6.2% with vitamin D and 9.3% received a combination of vitamin D and calcium. Specific osteoporosis treatment was prescribed to 7.2% only. In conclusion, this study reflects a high degree of continuing unawareness toward a diagnosis of osteoporosis in Austrian nursing homes and seniors' residences. The data of this survey further indicate that undertreatment is still very common in this population at very high risk of fractures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Anonymous (2001) Osteoporosis prevention, diagnosis and therapy. JAMA 285: 785–95

    Article  Google Scholar 

  • Dimai HP, Pietschmann P, Resch H, Preisinger E, Fahrleitner-Pammer A, Dobnig H, et al (2009) Austrian guidance for the pharmacological treatment of osteoporosis in postmenopausal women – update 2009. Wien Med Wochenschr 122[Suppl]: 1–34

    Article  Google Scholar 

  • Kanis JA, Burlet N, Cooper C, Delmas PD, Reginster JY, Borgstrom F, et al (2008) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 19(4): 399–428

    Article  CAS  PubMed  Google Scholar 

  • Solomon DH, Morris C, Cheng H, Cabral D, Katz JN, Finkelstein JS, et al (2005) Medication use patterns for osteoporosis: an assessment of guidelines, treatment rates, and quality improvement interventions. Mayo Clin Proc 80(2): 194–202

    Article  PubMed  Google Scholar 

  • Colón-Emeric C, Lyles KW, Levine DA, House P, Schenck A, Gorospe J, et al (2007) Prevalence and predictors of osteoporosis treatment in nursing home residents with known osteoporosis or recent fracture. Osteoporos Int 18(4): 553–9

    Article  PubMed  Google Scholar 

  • Wright RM (2007) Use of osteoporosis medications in older nursing facility residents. J Am Med Dir Assoc 8(7): 453–7

    Article  PubMed  Google Scholar 

  • Vik SA, Maxwell CJ, Hanley DA (2005) Treatment of osteoporosis in an older home care population. BMC Musculoskelet Disord 6: 7

    Article  PubMed  Google Scholar 

  • Panneman MJ, Lips P, Sen SS, Herings RM (2004) Undertreatment with anti-osteoporotic drugs after hospitalization for fracture. Osteoporos Int 15(2): 120–4

    Article  PubMed  Google Scholar 

  • Sloane PD, Gruber-Baldini AL, Zimmerman S, Roth M, Watson L, Boustani M, et al (2004) Medication undertreatment in assisted living settings. Arch Intern Med 164(18): 2031–7

    Article  PubMed  Google Scholar 

  • Rojas-Fernandez CH, Lapane KL, MacKnight C, Howard KA (2002) Undertreatment of osteoporosis in residents of nursing homes: population-based study with use of the Systematic Assessment of Geriatric Drug Use via Epidemiology (SAGE) database. Endocr Pract 8(5): 335–42

    PubMed  Google Scholar 

  • Haaland DA, Cohen DR, Kennedy CC, Khalidi NA, Adachi JD, Papaioannou A (2009) Closing the osteoporosis care gap – increased osteoporosis awareness among geriatrics and rehabilitation teams. BMC Geriatr 9(1): 28

    Article  PubMed  Google Scholar 

  • Gardner MJ, Flik KR, Mooar P, Lane JM (2002) Improvement in the undertreatment of osteoporosis following hip fracture. J Bone Joint Surg Am 84-A(8): 1342–8

    PubMed  Google Scholar 

  • Jaglal SB, Weller I, Mamdani M, Hawker G, Kreder H, Jaakkimainen L, et al (2005) Population trends in BMD testing, treatment, and hip and wrist fracture rates: are the hip fracture projections wrong? J Bone Miner Res 20(6): 898–905

    Article  PubMed  Google Scholar 

  • Kannus P, Niemi S, Parkkari J, Palvanen M, Vuori I, Järvinen M (2006) Nationwide decline in incidence of hip fracture. J Bone Miner Res 21(12): 1836–8

    Article  PubMed  Google Scholar 

  • Dorner T, Weichselbaum E, Lawrence K, Viktoria Stein K, Rieder A (2009) Austrian Osteoporosis Report: epidemiology, lifestyle factors, public health strategies. Wien Med Wochenschr 159(9–10): 221–9

    Article  PubMed  Google Scholar 

  • Dobnig H, Piswanger-Sölkner JC, Roth M, Obermayer Pietsch B, Tiran A, Strele A, Maier E, Maritschnegg P, Sieberer C, Fahrleitner-Pammer A (2006) Type 2 diabetes mellitus in nursing home patients: eff ects on bone turno-ver, bone mass, and fracture risk. J Clin Endocrin Metab 91(9): 3355–63

    Article  CAS  Google Scholar 

  • Dobnig H, Piswanger-Sölkner C, Obermayer-Pietsch B, Tiran A, Strele A, Maier E, Maritschnegg P, Riedmüller G, Brueck C, Fahrleitner-Pammer A (2007) Hip and nonvertebral fracture prediction in nursing home patients: role of bone ultrasound and bone marker measurements. J Clin Endocrin Metab 92(5): 1678–86

    Article  CAS  Google Scholar 

  • Frankfort SV, Tulner LR, van Campen JP, Koks CH, Beijnen JH (2006) Evaluation of pharmacotherapy in geriatric patients after performing complete geriatric assessment at a diagnostic day clinic. Clin Drug Investig 26(3): 169–74

    Article  CAS  PubMed  Google Scholar 

  • Rapp K, Becker C, Lamb SE, Icks A, Klenk J (2008) Hip fractures in institutionalized elderly people: incidence rates and excess mortality. J Bone Miner Res 23(11): 1825–31

    Article  PubMed  Google Scholar 

  • Zimmerman SI, Girman CJ, Buie VC, Chandler J, Hawkes W, Martin A, et al (1999) Th e prevalence of osteoporosis in nursing home residents. Osteoporos Int 9(2): 151–7

    Article  CAS  PubMed  Google Scholar 

  • Sallin U, Mellström D, Eggertsen R (2005) Osteoporosis in a nursing home, determined by the DEXA technique. Med Sci Monit 11(2): CR67–70

    PubMed  Google Scholar 

  • Kenny AM, Smith J, Noteroglu E, Waynik IY, Ellis C, Kleppinger A, et al (2009) Osteoporosis risk in frail older adults in assisted living. J Am Geriatr Soc 57(1): 76–81

    Article  PubMed  Google Scholar 

  • Bischoff -Ferrari HA, Willett WC, Wong JB, Stuck AE, Staehelin HB, Orav EJ, et al (2009) Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 169(6): 551–61

    Article  CAS  PubMed  Google Scholar 

  • Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, et al (1992) Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 327(23): 1637–4

    Article  CAS  PubMed  Google Scholar 

  • Boonen S, Laan RF, Barton IP, Watts NB (2005) Eff ect of osteoporosis treatments on risk of non-vertebral fractures: review and meta-analysis of intention-to-treat studies. Osteoporos Int 16(10): 1291–8

    Article  PubMed  Google Scholar 

  • Cole ZA, Dennison EM, Cooper C (2008) Osteoporosis epidemiology update. Curr Rheumatol Rep 10(2): 92–6

    Article  PubMed  Google Scholar 

  • Dennison E, Cole Z, Cooper C (2005) Diagnosis and epidemiology of osteoporosis. Curr Opin Rheumatol 17(4): 456–61

    Article  PubMed  Google Scholar 

  • Lyles KW, Schenck AP, Colón-Emeric CS (2008) Hip and other osteoporotic fractures increase the risk of subsequent fractures in nursing home residents. Osteoporos Int 19(8): 1225–33

    Article  CAS  PubMed  Google Scholar 

  • Sugarman JR, Connell FA, Hansen A, Helgerson SD, Jessup MC, Lee H (2002) Hip fracture incidence in nursing home residents and community-dwelling older people, Washington State, 1993–1995. J Am Geriatr Soc 50(10): 1638–43

    Article  PubMed  Google Scholar 

  • Chandler JM, Zimmerman SI, Girman CJ, Martin AR, Hawkes W, Hebel JR, et al (2000) Low bone mineral density and risk of fracture in white female nursing home residents. JAMA 284(8): 972–7

    Article  CAS  PubMed  Google Scholar 

  • Seeman E, Vellas B, Benhamou C, Aquino JP, Semler J, Kaufman JM (2006) Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older. J Bone Miner Res 21(7): 1113–20

    Article  CAS  PubMed  Google Scholar 

  • Lyles KW, Colón-Emeric CS, Magazinger JS, Adachi JD, Pieper CF, Mautalen C, Hyldstrup L, Recknor C, Nordsletten L, Moore KA, Lavecchia C, Zhang J, Mesenbrink P, Hodgson PK, Abrams K, Orloff JJ, Horowitz Z, Eriksen EF, Boonen S; HORIZON Recurrent Fracture Trial (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357(18): 1799–809

    Article  CAS  PubMed  Google Scholar 

  • Cramer JA, Gold DT, Silverman SL, Lewiecky EM (2007) A systematic review of persistence and compliance with bisphosphonates for osteoporosis. Osteoporos Int 18: 1023–31

    Article  CAS  PubMed  Google Scholar 

  • Delmas PD, Adami S, Strugala C, Stakkestad JA, Reginster JY, Felsenberg D, Christiansen C, Civitelli R, Drezner MK, Recker RR, Bolognese M, Hughes C, Masanauskaite D, Ward P, Sambrook P, Reid DM (2006) Intravenous ibandronate injections in postmenopausal women with osteoporosis: one-year results from the dosing intravenous administration study. Arthritis Rheum 54(6): 1838–46

    Article  CAS  PubMed  Google Scholar 

  • Sebba AI, Emkey RD, Kohles JD, Sambrook PN (2009) Ibandronate dose response is associated with increases in bone mineral density and reductions in clinical fractures: results of a meta-analysis. Bone 44(3): 423–7

    Article  CAS  PubMed  Google Scholar 

  • Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, Cosman F, Lakatos P, Leung PC, Man Z, Mautalen C, Mesenbrink P, Hu H, Caminis J, Tong K, Rosario-Jansen T, Krasnow J, Hue TF, Sellmeyer D, Eriksen EF, Cummings SR (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356(18): 1809–22

    Article  CAS  PubMed  Google Scholar 

  • Premaor MO, Pilbrow L, Tonkin C, Adams M, Parker RA, Compston J (2010) Low rates of treatment in postmenopausal women with a history of low trauma fractures: results of audit in a Fracture Liaison Service. QJM 103(1): 33–40

    Article  CAS  PubMed  Google Scholar 

  • Jensen J, Lundin-Olsson L, Nyberg L, Gustafson Y (2002) Fall and injury prevention in older people living in residential care facilities. A cluster randomized trial. Ann Intern Med 136(10): 733–41

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peter Pietschmann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pietschmann, P., Azizi-Semrad, U., Pils, K. et al. Pharmacologic undertreatment of osteoporosis in Austrian nursing homes and senior's residences. Wien Klin Wochenschr 122, 532–537 (2010). https://doi.org/10.1007/s00508-010-1428-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00508-010-1428-8

Keywords

Navigation